In this study on intravenous pantoprazole administration, no short-term problems with regard to efficacy or tolerability were observed when patients were switched from intravenous to oral therapy ...

This was an open-label, nationwide, multicentre, Phase IV study, performed in Austria. The 44 participating centres included academic as well as non-academic hospitals. Inclusion criteria were ...

A new report about the The Elder Scrolls IV: Oblivion Remake has revealed when the game is releasing, and it’s soon. The report doesn’t provide a precise release date, but a release window.

This launch follows the introduction of Edaravone IV Infusion in 2024. In 2023, PCC further expanded its portfolio with the launches of Pantoprazole Sodium for Injection, USP, and Doxycycline for ...

In 2024, PCC had launched the first to market generic of Edaravone IV Infusion, which followed 2023 launches of Pantoprazole Sodium for Injection, USP and Doxycycline for Injection, USP to further ...